News Image

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

Provided By PR Newswire

Last update: Aug 12, 2025

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This expansion is part of AbbVie's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical manufacturing capabilities and capacity.

Read more at prnewswire.com

ABBVIE INC

NYSE:ABBV (8/25/2025, 5:21:49 PM)

After market: 207.55 0 (0%)

207.55

-3.05 (-1.45%)



Find more stocks in the Stock Screener

ABBV Latest News and Analysis

Follow ChartMill for more